DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunity

Efficient delivery of DNA vaccines using human papillomavirus pseudovirions

(2010) S Peng et al.   GENE THERAPY

Enhancing the Therapeutic Effect Against Ovarian Cancer Through a Combination of Viral Oncolysis and Antigen-specific Immunotherapy

(2010) Yu-Qian Zhang et al.   MOLECULAR THERAPY

Treatment With Cyclooxygenase-2 Inhibitors Enables Repeated Administration of Vaccinia Virus for Control of Ovarian Cancer

(2009) Chih-Long Chang et al.   MOLECULAR THERAPY

Two Highly Conserved Cysteine Residues in HPV16 L2 Form an Intramolecular Disulfide Bond and Are Critical for Infectivity in Human Keratinocytes

(2009) Samuel K. Campos et al.   PLoS One

Role of L2 cysteines in papillomavirus infection and neutralization

(2009) Ratish Gambhira et al.   Virology Journal

Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer

(2008) C. Mennuni et al.   CANCER RESEARCH

A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3

(2008) C. L. Trimble et al.   CLINICAL CANCER RESEARCH